Zydus Life shares rise as US arm gains rights for rare paediatric disease drug on December 6, 2023 at 6:11 am

Zydus Lifesciences#39; arm has taken over the development and commercialization of CUTX-101, a product for treating Menkes disease

Leave a comment

Your email address will not be published. Required fields are marked *